Cargando…
Outlook for CRISPR-based tuberculosis assays now in their infancy
Tuberculosis (TB) remains a major underdiagnosed public health threat worldwide, being responsible for more than 10 million cases and one million deaths annually. TB diagnosis has become more rapid with the development and adoption of molecular tests, but remains challenging with traditional TB diag...
Autores principales: | Huang, Zhen, Zhang, Guoliang, Lyon, Christopher J., Hu, Tony Y., Lu, Shuihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436990/ https://www.ncbi.nlm.nih.gov/pubmed/37600797 http://dx.doi.org/10.3389/fimmu.2023.1172035 |
Ejemplares similares
-
CRISPR Assays for Disease Diagnosis: Progress to and Barriers Remaining for Clinical Applications
por: Huang, Zhen, et al.
Publicado: (2023) -
CRISPR-based assays for low-resource settings
por: Huang, Zhen, et al.
Publicado: (2023) -
Serum-Based Diagnosis of Pediatric Tuberculosis by Assay of Mycobacterium tuberculosis Factors: a Retrospective Cohort Study
por: He, Yifan, et al.
Publicado: (2021) -
Utility of recombinant fusion protein ESAT6-CFP10 skin test for differential diagnosis of active tuberculosis: A prospective study
por: Yuan, Yuan, et al.
Publicado: (2023) -
Clinical Outlook for Type-1 and FOXP3(+) T Regulatory Cell-Based Therapy
por: Gregori, Silvia, et al.
Publicado: (2015)